Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas R Powell

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Chronic Diseases and Translational Medicine|June 14, 2024
Analysis of the combined effect of rs699 and rs5051 on angiotensinogen expression and hypertensionNicholas R Powell, Tyler Shugg, Jacob Leighty, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Analysis of the Combined Effect of rs699 and rs5051 on Angiotensinogen Expression and HypertensionNicholas R Powell, Tyler Shugg, Jacob Leighty, et al.
Nature Communications|March 17, 2023
Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver diseaseNicholas R Powell, Tiebing Liang, Joseph Ipe, et al.
Clinical Pharmacology and Therapeutics|May 12, 2025
Evaluation of CYP2C19 Clinical Decision Support Alerts to Guide P2Y<sub>12</sub> Inhibitor PrescribingAshley N Springer, Leah A Alicea, Yemi Gafari, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Chronic Diseases and Translational Medicine|June 14, 2024
Analysis of the combined effect of rs699 and rs5051 on angiotensinogen expression and hypertensionNicholas R Powell, Tyler Shugg, Jacob Leighty, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Analysis of the Combined Effect of rs699 and rs5051 on Angiotensinogen Expression and HypertensionNicholas R Powell, Tyler Shugg, Jacob Leighty, et al.
Nature Communications|March 17, 2023
Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver diseaseNicholas R Powell, Tiebing Liang, Joseph Ipe, et al.
Clinical Pharmacology and Therapeutics|May 12, 2025
Evaluation of CYP2C19 Clinical Decision Support Alerts to Guide P2Y<sub>12</sub> Inhibitor PrescribingAshley N Springer, Leah A Alicea, Yemi Gafari, et al.
Pageof 2